Yesterday, ACIP—CDC’s external scientific advisory board—unanimously voted to authorize the Novavax vaccine (called NVX-CoV2373) in the U.S. This was big news for the small, underdog Maryland company who had a long road to authorization.
After rigorous clinical trials, FDA and CDC scientific meetings, and more than 1 million vaccines already rolled out …